The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pancreatic Cancer

Permuth, J., Dezsi, K., Vyas, S., Ali, K., Basinski, T., Utuama, O., Denbo, J., Klapman, J., Dam, A., Carballido, E., Kim, D., Pimiento, J., Powers, B., Otto, A., Choi, J., Chen, D., Teer, J., Beato, F., Ward, A., Cortizas, E., Whisner, S., Williams, I., Riner, A., Tardif, K., Velanovich, V., Karachristos, A., Douglas, W., Legaspi,…

Read More

Preclinical Evaluation of MEDI0641, a Pyrrolobenzodiazepine Conjugated Antibody–Drug Conjugate Targeting 5T4

Harper, Lloyd, Dimasi, Toader, Marwood, Lewis, Bannister, Jovanovic, Fleming, d’Hooge, Mao, Marrero, Korade, Strout, Xu, Chen, Wetzel, Breen, van Vlerken-Ysla, Jalla, Rebelatto, Zhong, Hurt, Hinrichs, Huang, Howard, Tice, Hollingsworth, Herbst, Kamal. Preclinical Evaluation of MEDI0641, a Pyrrolobenzodiazepine Conjugated Antibody–Drug Conjugate Targeting 5T4. Mol Cancer Ther; 16(8) August 2017. DOI: 10.1158/1535-7163.MCT-16-0825

Read More